Is the immediate blood pressure control using parenteral antihypertensive drug needed for patients with severe high blood pressure with epistaxis in the emergency department?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, Kyunghoon | - |
dc.contributor.author | Park, Kyunghoon | - |
dc.contributor.author | Lee, Heekyung | - |
dc.contributor.author | Kim, Changsun | - |
dc.contributor.author | Kim, Laurie Seiwon | - |
dc.contributor.author | Yoo, Ji Won | - |
dc.date.accessioned | 2023-06-01T07:15:59Z | - |
dc.date.available | 2023-06-01T07:15:59Z | - |
dc.date.created | 2023-05-03 | - |
dc.date.issued | 2022-10 | - |
dc.identifier.issn | 1226-4334 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/185983 | - |
dc.description.abstract | Objective: This study aimed to assess whether the conventional treatments administered in the emergency department (ED) for hypertensive urgencies (observed or peroral [PO]-controlled) in severe high blood pressure (BP) patients with epistaxis increase the incidence of epistaxis recurrence and the mortality rate as compared to immediate BP control using intravenous (IV) antihypertensive medication Methods: A retrospective study over 7 years was conducted at the ED of a tertiary university hospital. Among adult patients with spontaneous epistaxis, subjects with severe high BP (systolic BP ≥180 mmHg or diastolic BP ≥120 mmHg) were included in the study. Participants were divided into three groups determined by the methods used to control BP: non-controlled, PO-controlled, and IV-controlled groups. The incidence of epistaxis recurrence and mortality rate within 6 months were compared. Results: Among the 380 patients enrolled, 238 were discharged from the ED without any pharmacological antihypertensive treatment (non-controlled group), 83 received PO antihypertensive medication (PO-controlled group), and 59 received IV antihypertensive medication (IV-controlled group). Of these, 29 (12.2%), nine (10.8%), and seven (11.9%) patients from the non-controlled, PO-controlled, and IV-controlled groups, respectively, experienced epistaxis recurrence within 24 hours, which was statistically not different among the three groups (P=0.948). The 6-month mortality rates were determined to be 0.8%, 2.4%, and 3.4% in the non-controlled, PO-controlled, and IV-controlled groups, respectively. The difference was also not significant among the groups (P=0.294). Conclusion: The conventional treatments of hypertensive urgencies (observed or PO-controlled) in patients with severe high BP with epistaxis in the ED did not increase the incidence of epistaxis recurrence and short-term mortality rate when compared to immediate BP control using IV antihypertensive medication. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한응급의학회 | - |
dc.title | Is the immediate blood pressure control using parenteral antihypertensive drug needed for patients with severe high blood pressure with epistaxis in the emergency department? | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Heekyung | - |
dc.contributor.affiliatedAuthor | Kim, Changsun | - |
dc.identifier.bibliographicCitation | 대한응급의학회지, v.33, no.5, pp.471 - 479 | - |
dc.relation.isPartOf | 대한응급의학회지 | - |
dc.citation.title | 대한응급의학회지 | - |
dc.citation.volume | 33 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 471 | - |
dc.citation.endPage | 479 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART002893732 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Epistaxis | - |
dc.subject.keywordAuthor | Severe high blood pressure | - |
dc.subject.keywordAuthor | Hypertensive crisis | - |
dc.identifier.url | https://kiss.kstudy.com/Detail/Ar?key=3978712 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.